Our Commitment to Public Health

As a global leader in in vitro diagnostics and infectious disease management for over 55 years, bioMérieux has always been driven by an unrelenting commitment to improve public health worldwide. With expertise, partnerships, and proprietary research, bioMerieux has been standing alongside health organizations and providers to combat the spread of infectious disease, including the SARS-CoV-2 virus, which the World Health Organization declared a global pandemic on March 11, 2020.

Our Latest COVID-19 Developments

Test Updates

To help governments and healthcare professionals fight the spreading pandemic COVID-19 in this unprecedented global health crisis, we can currently provide our customers with solutions from extraction through real-time PCR diagnosis. We currently have 2 complementary diagnostic solutions and have a third test under development. Our tests have the necessary high quality, validation and regulatory market approvals to assure patient and lab professional confidence.

The BIOFIRE® SARS-CoV-2 test has received Emergency Use Authorization (EUA) from the FDA on March 24th. This single pathogen assay was developed with funds from the U.S. Department of Defense (DOD). While the DOD has priority access to the BioFire COVID-19 Test, we are providing a limited quantity to some of our non-DOD customers. View the press release >

The SARS-COV-2 R-GENE® test is a real-time PCR assay produced in France and has been available as CE marked since April 10th and received Emergency Use Authorization (EUA) from the FDA on May 6, 2020. 

The BIOFIRE® RP2.1 Panel is our syndromic solution to the COVID-19 pandemic. It includes SARS-CoV-2 as well as 21 additional common respiratory pathogens. This assay has received Emergency Use authorization from the FDA on May 1, 2020.

In addition to the development of diagnostic tests for the detection of SARS-CoV-2, we are actively collaborating and standing alongside healthcare facilities and organizations, frontline medical professionals, and advocacy groups to support the management of the crisis with all knowledge and resources available today.

 

       

Educational Resources

Use the links below to view additional resources regarding COVID-19. We will continually update this section as materials become available.

bioMérieux Connection Articles - COVID-19

COVID-19 is a highly contagious virus that is creating an urgent need for answers about how to combat it, treat it and care for secondary infections that may arise. Scientists are tirelessly working to find the virus origins, study how it behaves, and identify what might kill it or prevent it. Learn more at bioMerieuxConnection.com.

How the COVID-19 Test Works

Treatment for COVID-19

Epidemiological Data and COVID-19

bioMérieux Connection Articles - Antimicrobial Stewardship

Many studies have already found that a significant number of hospitalized COVID-19 patients are continuing to develop dangerous – and sometimes deadly – secondary bacterial co-infections, such as bacterial pneumonia and sepsis. It’s never been more critical to consider the global threat that antimicrobial resistance poses to human health. Diagnostic considerations are a key factor in advancing Antimicrobial Stewardship – and helping the medical and scientific communities to gain new strength in the ongoing fight against COVID-19. Learn more at bioMerieuxConnection.com.

Whole Genome Seqencing

Antibiotic Treatment Duration

AMR and COVID-19

Frequently Asked Questions

HOW IS BIOMÉRIEUX MANAGING SERVICE CONTINUITY?

bioMérieux is fully committed to delivering the quality service and support our customers need. We have also taken precautionary measures to reduce our employees' risk of exposure to COVID-19 by asking non-essential employees to work remotely. Our Field Service Team (including Engineer and Application team members) will be available during normal business hours, and our customer hotline is available 24 hours a day and 7 days a week.

Furthermore, we remind our valued customers to utilize remote access technology for rapid response, such as VILINK® (remote instrument support).

HOW IS BIOMÉRIEUX MANAGING MANUFACTURING OF NEW TESTS AND INCREASED REQUESTS FOR INSTRUMENTATION?

bioMérieux is increasing manufacturing capabilities to ensure our essential products are available to meet the anticipated increase in demand for the new ARGENE® and BIOFIRE® tests.

DOES BIOMÉRIEUX ANTICIPATE DISRUPTION IN THE SUPPLY OF ITS PRODUCTS TO CUSTOMERS?

We recognize the essential role our products play in the detection and diagnosis of COVID-19 and would like to assure you that bioMérieux will be doing all that it can to support you during this unprecedented time we are all facing together. The magnitude of the current demand is challenging the entire healthcare community.

In general, the raw materials used in bioMérieux products are produced by a variety of major life science companies. In particular, the producers of raw materials used in molecular biology are facing an exploding demand. We are taking active measures to stay in close cooperation with our raw material suppliers and consolidate our long-term partnerships.

DOES BIOMÉRIEUX ANTICIPATE DISRUPTION IN THE TRANSPORTATION OF ITS PRODUCTS TO CUSTOMERS?

The international freight and air transportation sectors are severely impacted by the current situation, and bioMérieux is working continuously with its carriers to secure deliveries. As of now, the routes from bioMérieux International Distribution Centers to most countries are still operating, and delivery of products to customers has not been disrupted. The situation is nevertheless evolving daily and may result in delayed shipments to the United States.

More information can be found at www.biomerieux.com

WHAT GUIDELINES ARE IN PLACE TO PROTECT BIOMÉRIEUX EMPLOYEES?

Our employees’ safety is our top priority. Our subsidiaries are following advice and regulations from local government and health agencies and making the appropriate adjustments to operations. Several measures have already been taken to protect our employees all over the world, including work-from-home capabilities and limiting onsite presence to only essential employees. Other safety measures include, but are not limited to: employee temperature checks, adhering to strict social distancing when possible, mask usage and protection kits for our Field Service Engineers and Field Application Specialists. The kits for our Field employees include disposable FFP3 masks, gloves, disinfecting wipes, disposable gowns, and a bottle of hydroalcoholic gel.

Order Tracking

In order to provide you information about the status of your open orders, track product shipments and receive real-time information related to bioMérieux’s business related to the COVID-19 pandemic, we have created customized portals for our extraction reagents and BIOFIRE® panels.

To login, all you will need is your customer ID number. Visit our portals below:

NUCLISENS® Allocation Website BioFire® Allocation Website

Need More Information?